{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:49:48Z","timestamp":1791985788800,"version":"4.4.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To evaluate the diagnostic efficacy of magnetic resonance imaging (MRI)-based signal intensity ratio (SIR) between extraocular muscles and white matter\/temporal muscle for staging thyroid eye disease (TED) activity, and to provide a novel approach for diagnosis in active TED patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A number of 40 patients with TED (79 eyes) and 65 controls (65 eyes) were recruited. MRI-based parameters of four extraocular muscles, ipsilateral white matter, temporal muscle, and other clinical factors were retrospectively collected. Patients were grouped according to disease activity determined by the Clinical Activity Score (CAS), and intergroup analysis was subsequently performed based on this classification. The signal intensities were measured using fat-suppressed T2-weighted imaging (T2WI-FS) sequences from MRI. The SIR of the extraocular rectus muscle to that of the ipsilateral white matter represents SIR1, while the SIR of the extraocular rectus muscle to that of the ipsilateral temporalis muscle represents SIR2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Active TED group demonstrated elevated SIR1 and SIR2 values across all rectus muscles compared to control group and inactive TED group (P&amp;lt;0.05), with no differences between inactive TED and controls. Receiver operator characteristic (ROC) curve analysis identified SIR2 as superior to SIR1 for most muscles, with inferior rectus SIR1 achieving the highest AUC (0.837). Based on 95% confidence intervals and cutoff values, we propose redefining TED staging: control ranges (0.936\u20131.019) as absolute inactive phase, active TED ranges (1.210\u20131.344) as absolute active phase, and transitional values (1.019\u20131.210) as clinical vigilance phase requiring heightened attention. The model suggests that patients currently defined as \u201cinactive\u201d by CAS may have subclinical inflammation, explaining paradoxical disease progression in some cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The signal intensity ratio (SIR) from fat-suppressed T2-weighted (T2WI-FS) sequences serves as a reliable predictor for TED activity. The 95% confidence interval (CI) for SIR values can provide a new strategy for early diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1650116","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T04:16:18Z","timestamp":1757650578000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["MRI-based SIR quantitative biomarkers: a novel imaging diagnostic strategy for thyroid eye disease activity staging"],"prefix":"10.3389","volume":"16","author":[{"given":"Muhan","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 Ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"B2","article-title":"Development and course of exophthalmos and ophthalmoplegia in Graves\u2019 disease with special reference to the effect of thyroidectomy","volume":"5","author":"Rundle","year":"1945","journal-title":"Clin Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of graves\u2019 Orbitopathy","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2265.1997.2070991.x","article-title":"Clinical activity score as a guide in the management of patients with Graves\u2019 orbitopathy","volume":"47","author":"Rose","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1167\/iovs.13-12741","article-title":"Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype","volume":"54","author":"Kuriyan","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"28960","DOI":"10.1038\/s41598-024-76624-2","article-title":"Orbital computed tomography imaging characteristics of thyroid-associated ophthalmopathy","volume":"14","author":"Xiong","year":"2024","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02367-5","article-title":"Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues","volume":"70","author":"Hu","year":"2020","journal-title":"Endocrine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02873-0","article-title":"Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy","volume":"75","author":"Ma","year":"2022","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12902-021-00895-3","article-title":"Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence","volume":"21","author":"Ge","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13244-024-01693-w","article-title":"Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy","volume":"15","author":"Pu","year":"2024","journal-title":"Insights Imaging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13244-024-01757-x","article-title":"Extraocular muscle Diffusion Weighted Imaging as a quantitative metric of posterior orbital involvement in thyroid associated orbitopathy","volume":"15","author":"George","year":"2024","journal-title":"Insights Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1210\/clinem\/dgae526","article-title":"Effectiveness of different treatment modalities in initial and chronic phases of thyroid eye disease: A systematic review with meta-analysis","volume":"109","author":"Alves Junior","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0251","article-title":"Management of thyroid eye disease: A consensus statement by the american thyroid association and the european thyroid association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30046-8","article-title":"Advances in treatment of active, moderate-to-severe Graves\u2019 ophthalmopathy","volume":"5","author":"Wiersinga","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-014-3103-3","article-title":"Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg","volume":"24","author":"Politi","year":"2014","journal-title":"Eur Radiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176064","article-title":"Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06555-x","article-title":"A foundation model for generalizable disease detection from retinal images","volume":"622","author":"Zhou","year":"2023","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12659\/pjr.883622","article-title":"Signal intensity and T2 time of extraocular muscles in assessment of their physiological status in MR imaging in healthy subjects","volume":"77","author":"Paj\u0105k","year":"2012","journal-title":"Pol J Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-014-0365-x","article-title":"Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy","volume":"59","author":"Higashiyama","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k10e-156","article-title":"Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves\u2019 ophthalmopathy","volume":"57","author":"Tachibana","year":"2010","journal-title":"Endocr J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6664","article-title":"Non-EPI-DWI for detection, disease monitoring, and clinical decision-making in thyroid eye disease","volume":"41","author":"Feeney","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/jcp-2022-208290","article-title":"Thyroid autoantibodies","volume":"76","author":"Dwivedi","year":"2023","journal-title":"J Clin Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02318-6","article-title":"Fibulin-1: a novel biomarker for predicting disease activity of the thyroid-associated ophthalmopathy","volume":"37","author":"Hu","year":"2023","journal-title":"Eye (Lond)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1340415","article-title":"Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves\u2019 orbitopathy","volume":"15","author":"H\u00f6tte","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.clinbiochem.2021.07.014","article-title":"Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves\u2019 disease and predictors of responsiveness to methimazole","volume":"97","author":"Liu","year":"2021","journal-title":"Clin Biochem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.005","article-title":"Epidemiology of Graves\u2019 orbitopathy (GO) and relationship with thyroid disease","volume":"26","author":"Lazarus","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1650116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T04:16:19Z","timestamp":1757650579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1650116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":29,"alternative-id":["10.3389\/fendo.2025.1650116"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1650116","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"article-number":"1650116"}}